 lack effect peror acyclovir treatment acut infecti mononucleosi acyclovir therapi acut infecti mononucleosi multicent double-blind placebo-control trial total patient mg acyclovir placebo time day patient studi day symptom onset posit monospot test analysi mean valu time resolut fever lymphadenopathi weight chang hepatomegali splenomegali liver function test atyp lymphocyt hour bed rest sens well-b normal activ signific differ trend suppress epstein-barr viru excret oropharynx acyclovir recipi toxic patient acyclovir condit studi evid treatment cours infecti mononucleosi